An overview of the revised European Medicines Agency guideline on the clinical investigation of medicinal products for the treatment or prevention of type 1 and 2 diabetes.
Practical advice on how to use tirzepatide in the management of type 2 diabetes, according to the clinical profile and therapeutic goals. Learn about adverse events, special warnings, precautions, and more.
PMS and diabetes share many physical and psychological symptoms, but what is the relationship between the two, and could anti-diabetic drugs have a favorable impact on the symptoms of PMS?
A range of effective medical and non-medical interventions are available for treating peripheral artery disease, so why are major adverse cardiovascular and limb outcomes still so prevalent?
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
Rapidly progressive insulin-dependent diabetes in the absence of islet autoantibodies developed 2 years after starting treatment with the immune checkpoint inhibitor nivolumab.
HC-HB is a rare movement disorder that can occur in patients with poorly controlled diabetes and hyperglycemia without ketoacidosis. The mainstay of treatment is prompt correction of hyperglycemia.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
The role of automated insulin delivery systems in diabetes is expanding. Hybrid closed-loop systems are being used in routine clinical practice for treating people with type 1 diabetes. Encouragingly, real-world data reflects the performance and …
The escalating prevalence of type 2 diabetes mellitus (T2DM) has become a pressing public health issue, with projections indicating a substantial increase in diagnosed cases over the next two decades [ 1 ]. Similarly, the World Health Organization …
Obesity is a multifaceted condition, with an increasing incidence and prevalence worldwide [ 1 ]. Treatment options for obesity are currently limited, and the condition is associated with a higher risk of dyslipidemia, type 2 diabetes mellitus …
In recent years, the potential of stem cells (SCs) to differentiate into various types of cells, including β-cells, has led to a significant boost in development. The efficiency of this differentiation process and the functionality of the cells …
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
Diabetes is a metabolic disorder characterised by the inability of pancreatic beta cells to control blood glucose levels. The aetiology of the most common form, type 2 diabetes, is heterogeneous, although population genetic studies have identified …
Breast cancer continues to be an important health problem and is one of the most common causes of cancer deaths in women worldwide, with an estimated 358,967 new cases and 90,665 breast cancer-related deaths in the European Union annually [ 1 ].
Impaired renal function is a common long-term complication of diabetes mellitus as up to 40% of individuals with diabetes develop chronic kidney disease [ 1 , 2 ]. It is well known that renal impairment can alter drug pharmacokinetics, potentially …
Open AccessSleep ApneaSleep Breathing Physiology and Disorders • Original Article
Due to unhealthy dietary habits, sedentary lifestyles, and irregular work-rest routines, the prevalence of Metabolic Syndrome (MS) in China has seen a steady increase in recent years. According to data from the Chinese Center for Disease Control …
